Figure 4.
Selective and non-selective drugs for acute myeloid leukemia (AML). Different classes of drugs have been used for the treatment AML, which can be further classified as selective (e.g., flavopiridol) and non-selective drugs (e.g., mitoxantrone and guadecitabine), based on their targets and their mechanisms of action (MOA).